16-2088196-TAGTG-T
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_000548.5(TSC2):c.5161-28_5161-25delTGAG variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0101 in 1,612,902 control chromosomes in the GnomAD database, including 128 homozygotes. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0082 ( 10 hom., cov: 33)
Exomes 𝑓: 0.010 ( 118 hom. )
Consequence
TSC2
NM_000548.5 intron
NM_000548.5 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.09
Publications
1 publications found
Genes affected
TSC2 (HGNC:12363): (TSC complex subunit 2) This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
TSC2 Gene-Disease associations (from GenCC):
- tuberous sclerosisInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- tuberous sclerosis 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Ambry Genetics
- lymphangioleiomyomatosisInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- tuberous sclerosis complexInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP6
Variant 16-2088196-TAGTG-T is Benign according to our data. Variant chr16-2088196-TAGTG-T is described in ClinVar as Likely_benign. ClinVar VariationId is 49945.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00824 (1255/152226) while in subpopulation SAS AF = 0.0141 (68/4832). AF 95% confidence interval is 0.0115. There are 10 homozygotes in GnomAd4. There are 591 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 1255 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00827 AC: 1258AN: 152108Hom.: 10 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
1258
AN:
152108
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00860 AC: 2155AN: 250500 AF XY: 0.00922 show subpopulations
GnomAD2 exomes
AF:
AC:
2155
AN:
250500
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0103 AC: 15017AN: 1460676Hom.: 118 AF XY: 0.0106 AC XY: 7718AN XY: 726638 show subpopulations
GnomAD4 exome
AF:
AC:
15017
AN:
1460676
Hom.:
AF XY:
AC XY:
7718
AN XY:
726638
show subpopulations
African (AFR)
AF:
AC:
53
AN:
33478
American (AMR)
AF:
AC:
172
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
167
AN:
26134
East Asian (EAS)
AF:
AC:
57
AN:
39700
South Asian (SAS)
AF:
AC:
1420
AN:
86250
European-Finnish (FIN)
AF:
AC:
277
AN:
52328
Middle Eastern (MID)
AF:
AC:
33
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
12307
AN:
1111920
Other (OTH)
AF:
AC:
531
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
972
1944
2917
3889
4861
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
456
912
1368
1824
2280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00824 AC: 1255AN: 152226Hom.: 10 Cov.: 33 AF XY: 0.00794 AC XY: 591AN XY: 74448 show subpopulations
GnomAD4 genome
AF:
AC:
1255
AN:
152226
Hom.:
Cov.:
33
AF XY:
AC XY:
591
AN XY:
74448
show subpopulations
African (AFR)
AF:
AC:
58
AN:
41536
American (AMR)
AF:
AC:
119
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
20
AN:
3466
East Asian (EAS)
AF:
AC:
2
AN:
5182
South Asian (SAS)
AF:
AC:
68
AN:
4832
European-Finnish (FIN)
AF:
AC:
38
AN:
10620
Middle Eastern (MID)
AF:
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
AC:
830
AN:
67970
Other (OTH)
AF:
AC:
21
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
68
136
203
271
339
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
13
AN:
3476
ClinVar
Significance: Likely benign
Submissions summary: Benign:1Other:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Tuberous sclerosis syndrome Other:2
-
Tuberous sclerosis database (TSC2)
Significance:not provided
Review Status:no classification provided
Collection Method:curation
- -
Apr 06, 2011
Tuberous sclerosis database (TSC2)
Significance:not provided
Review Status:no classification provided
Collection Method:curation
- -
not provided Benign:1
Jun 23, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.